Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience

Gabriel De-La-Cruz-Ku, Marianne Luyo, Zaida Morante, Daniel Enriquez, Mecker G. Möller, Diego Chambergo-Michilot, Lucero Flores, Renato Luque, Antonella Saavedra, Miguel E. Eyzaguirre-Sandoval, María G. Luján-Peche, Naysha Noel, Hafid Calderon, Cesar Razuri, Hugo A. Fuentes, Jose Manuel Cotrina, Silvia P. Neciosup, Jhajaira Araujo, Alexandra Lema, Joseph PintoHenry L. Gomez, Bryan Valcarcel

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

11 Citas (Scopus)


Background Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overall survival (OS) of a Peruvian population with triple-negative breast cancer. Methods We reviewed the medical records of new cases treated at a single institution in the period 2000–2014. The survival analysis included patients with stages I-IV. Survival estimates at 10 years were calculated with the Kaplan-Meier method and compared with the Log-rank test. We further used multivariate Cox regression analysis to calculate prognostic factors of recurrence and mortality. Results Among the 2007 patients included, the median age at diagnosis was 49 years (19–95 years). Most patients presented histologic grade III (68.7%), tumor stage II (34.2%), and III (51.0%) at diagnosis. Local and distant relapse was present in 31.9 and 51.4% of the patients, respectively. The most frequent sites of metastasis were the lungs (14.5%), followed by bone (9.7%), brain (9.6%), and liver (7.9%). The median follow-up was 153 months. At 3, 5, and 10 years, the EFS of the population was 55%, 49%, and 41%, respectively, while the OS was 64%, 56%, and 47%, respectively. Moreover, an N3 lymph node status was the most important prognostic factor for both disease relapse (HR: 2.54, 95% CI: 2.05–3.15) and mortality (HR: 2.51, 95% CI: 2.01–3.14) at ten years. An older age and higher T staging were associated with a worse OS, while patients who received radiotherapy and adjuvant chemotherapy had better survival rates. Conclusion The sociodemographic features of Peruvian patients with TNBC are similar to those of other populations. However, our population was diagnosed at more advanced clinical stages, and thus, EFS and OS were lower than international reports while prognostic factors were similar to previous studies.

Idioma originalInglés
Número de artículoe0237811
PublicaciónPLoS ONE
N.º8 August 2020
EstadoPublicada - ago. 2020


Profundice en los temas de investigación de 'Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience'. En conjunto forman una huella única.

Citar esto